Technical Data
| Product # | AG10012 |
| Product name | Anti-GP88/Progranulin IHC Control Slides |
Applications
| IHC |
Yes Working concentrations for your specific applications should be determined by the investigator. Appropriate concentrations will be affected by several factors, including secondary antibody affinity, antigen concentration, sensitivity of detection method, temperature, and length of incubations, etc. |
Handling Requirements
| Storage | Store at -20°C. Avoid repeated freezing and thawing. |
Notes
| Notes Text |
Description: Formalin Fixed Paraffin Embedded Cells Quantity: 5 Positive / 5 Negative |
References
| References Text | Progranulin (GP88) tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinoma. Ginette Serrero, Douglas M Hawkins, Binbin Yue, Olga Ioffe, Pablo Bejarano, Jeffrey T Phillips, Jonathan F Head, Robert L Elliott, Katherine R Tkaczuk, Andrew K Godwin, JoEllen Weaver, Wes E Kim Breast Cancer Research 2012, 14:R26 (8 February 2012) |
IHC
| IHC Text |
Anti-GP88/PGRN recognizes Progranulin expressing cells. GP88/PGRN NAMES GP88/PGRN is also known as Progranulin, PC cell-derived growth factor (PCDGF), granulin-epithelin, acrogranin, GEP, PEPI, proepithelin. INTELLECTUAL PROPERTY This antibody is subject to Intellectual Property and owned exclusively by A&G Pharmaceutical, Inc. |
